Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa C Rohan

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|June 26, 2013
Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral DrugsAtsuko Hachiya, Aaron B Reeve, Bruno Marchand, et al.
Journal of the International AIDS Society|August 14, 2018
FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovirKatherine E Bunge, Charlene S Dezzutti, Craig W Hendrix, et al.
Plos One|February 23, 2010
In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicideLisa C Rohan, Bernard J Moncla, Ratiya Pamela Kunjara Na Ayudhya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2025
Rectal Douche as HIV Pre-Exposure Prophylaxis for Receptive Anal Intercourse: An End User Tenofovir Powder Sachet Preparation Feasibility Study (DREAM-04)Clarissa P Diniz, Sandra Abdul-Massih, Christina Bagia, et al.
Scientific Reports|December 4, 2019
Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosaGökçe Günaydın, Gabriella Edfeldt, David A Garber, et al.
AIDS Research and Human Retroviruses|September 29, 2020
The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal SexKate M Guthrie, Joseph L Fava, Sara E Vargas, et al.
Plos One|December 3, 2010
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaquesAlexander M Cole, Dorothy L Patton, Lisa C Rohan, et al.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
AIDS Research and Human Retroviruses|August 1, 2015
A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02)Hiwot Hiruy, Edward J Fuchs, Mark A Marzinke, et al.
Scientific Reports|May 26, 2018
Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primatesLauren Girard, Kenzie Birse, Johanna B Holm, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|June 26, 2013
Evaluation of Combinations of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine with Clinically Used Antiretroviral DrugsAtsuko Hachiya, Aaron B Reeve, Bruno Marchand, et al.
Journal of the International AIDS Society|August 14, 2018
FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovirKatherine E Bunge, Charlene S Dezzutti, Craig W Hendrix, et al.
Plos One|February 23, 2010
In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicideLisa C Rohan, Bernard J Moncla, Ratiya Pamela Kunjara Na Ayudhya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 23, 2025
Rectal Douche as HIV Pre-Exposure Prophylaxis for Receptive Anal Intercourse: An End User Tenofovir Powder Sachet Preparation Feasibility Study (DREAM-04)Clarissa P Diniz, Sandra Abdul-Massih, Christina Bagia, et al.
Scientific Reports|December 4, 2019
Impact of Q-Griffithsin anti-HIV microbicide gel in non-human primates: In situ analyses of epithelial and immune cell markers in rectal mucosaGökçe Günaydın, Gabriella Edfeldt, David A Garber, et al.
AIDS Research and Human Retroviruses|September 29, 2020
The Role of Volume in the Perceptibility of Topical Vaginal Formulations: User Sensory Perceptions and Experiences of Heterosexual Couples During Vaginal SexKate M Guthrie, Joseph L Fava, Sara E Vargas, et al.
Plos One|December 3, 2010
The formulated microbicide RC-101 was safe and antivirally active following intravaginal application in pigtailed macaquesAlexander M Cole, Dorothy L Patton, Lisa C Rohan, et al.
The Journal of Biological Chemistry|June 28, 2014
4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) inhibits HIV-1 reverse transcriptase with multiple mechanismsEleftherios Michailidis, Andrew D Huber, Emily M Ryan, et al.
AIDS Research and Human Retroviruses|August 1, 2015
A Phase 1 Randomized, Blinded Comparison of the Pharmacokinetics and Colonic Distribution of Three Candidate Rectal Microbicide Formulations of Tenofovir 1% Gel with Simulated Unprotected Sex (CHARM-02)Hiwot Hiruy, Edward J Fuchs, Mark A Marzinke, et al.
Scientific Reports|May 26, 2018
Impact of the griffithsin anti-HIV microbicide and placebo gels on the rectal mucosal proteome and microbiome in non-human primatesLauren Girard, Kenzie Birse, Johanna B Holm, et al.
Pageof 9